Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM3L75Sedative hypnotic drugs or other central nervous system depressants
Sedative-hypnotic and anxiolytic drugs
Benzodiazepines

XM4BU2 category

Cinolazepam

Also indexed as

Cinolazepam

Nearby in Benzodiazepines

XM1030Alprazolam
XM4R58Bentazepam
XM2GL0Benzodiapin
XM9JC7Bromazepam
XM2S43Brotizolam
XM5133Camazepam
XM9S41Carpipramine
XM1J81Central nervous system depressants benzodiazepines

PreviousXM66N4 — Doxefazepam

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
XM4G94Antidepressants
XM98Y0Cannabinoids or hallucinogens
XM9NV2Opioids
XM0RE9Psychostimulants
XM3L75Sedative hypnotic drugs or other central nervous system depressants
XM16M6Other or unspecified drugs, medicaments and biological substances
XM0YW5Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological or dental drugs
14 more
Anaesthetics and therapeutic gases
Sedative-hypnotic and anxiolytic drugs
XM2XY64-Aminobutyric acid
Benzodiazepines
XM8CM3Diphenylmethane derivatives
XM96H3Carbamates
XM3XU7Aldehydes and derivatives
XM6R00Piperidinedione derivatives
XM4YG0Barbiturates and derivatives
XM4843Z-drugs
XM0GA0Melatonin receptor agonists
Bromine compounds
4 more
XM4FQ9Nordazepam
XM1A29Oxazepam
XM62U2Oxazolam
XM3LR9Perlapine
XM0GW7Pinazepam
XM4M86Prazepam
XM42F4Quazepam
XM3215Temazepam
XM79N8Tofisopam
XM9X46Tranquilizer benzodiazepine
XM1VC3Triazolam
XM36R8Potassium clorazepate
XM94Z2Adinazolam
XM66N4Doxefazepam
XM4BU2Cinolazepam
34 more

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact